These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 25912325)

  • 1. [Complications after TACE in HCC].
    Schneeweiß S; Horger M; Ketelsen D; Ioanoviciu SD
    Rofo; 2015 May; 36(2):79-82. PubMed ID: 25912325
    [No Abstract]   [Full Text] [Related]  

  • 2. [7. Inspection of Hepatocellular Carcinoma 5: Angiography].
    Takao Y
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2016 Jul; 72(7):627-35. PubMed ID: 27440707
    [No Abstract]   [Full Text] [Related]  

  • 3. Pulmonary lipiodol embolism after transcatheter arterial chemoembolization for hepatocellular carcinoma: a case report and literature review.
    Naorungroj T; Naksanguan T; Chinthammitr Y
    J Med Assoc Thai; 2013 Feb; 96 Suppl 2():S270-5. PubMed ID: 23590054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Massive gastric ulceration after transarterial chemoembolization for hepatocellular carcinoma.
    Morante A; Romano M; Cuomo A; de Sio I; Cozzolino A; Mucherino C; Salerno R; Blanco Cdel V; Romano M
    Gastrointest Endosc; 2006 Apr; 63(4):718-20. PubMed ID: 16564887
    [No Abstract]   [Full Text] [Related]  

  • 5. [Gallbladder Perforation after Transarterial Chemoembolization in a Patient with a Huge Hepatocellular Carcinoma].
    Son MY; Han BH; Lee SU; Yun BC; Seo KI; Huh JD
    Korean J Gastroenterol; 2020 Jun; 75(6):351-355. PubMed ID: 32581207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic and biliary damage after transarterial chemoembolization for malignant hepatic tumors: incidence, diagnosis, treatment, outcome and mechanism.
    Sun Z; Li G; Ai X; Luo B; Wen Y; Zhao Z; Dong S; Guan J
    Crit Rev Oncol Hematol; 2011 Aug; 79(2):164-74. PubMed ID: 20719529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver/biliary injuries following chemoembolisation of endocrine tumours and hepatocellular carcinoma: lipiodol vs. drug-eluting beads.
    Guiu B; Deschamps F; Aho S; Munck F; Dromain C; Boige V; Malka D; Leboulleux S; Ducreux M; Schlumberger M; Baudin E; de Baere T
    J Hepatol; 2012 Mar; 56(3):609-17. PubMed ID: 22027582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Complications after TACE in HCC - complications after transarterial chemoembolization (TACE) in hepatocellular carcinoma].
    Schneeweiß S; Horger M; Ketelsen D; Ioanoviciu SD
    Rofo; 2015 Feb; 187(2):79-82. PubMed ID: 25629286
    [No Abstract]   [Full Text] [Related]  

  • 9. Massive hepatic necrosis with gastric, splenic, and pancreatic infarctions after ethanol ablation for hepatocellular carcinoma.
    Da Ines D; Buc E; Petitcolin V; Flamein R; Lannareix V; Achim A; Garcier JM
    J Vasc Interv Radiol; 2010 Aug; 21(8):1301-5. PubMed ID: 20598566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute renal failure as a complication of transarterial chemoembolization in a patient with hepatocellular carcinoma].
    La Spada E; La Spada M; Brusca T; Campagna ME; Di Gesaro V; Terranova A; Sandonato L; Soresi M
    Recenti Prog Med; 2007 Apr; 98(4):232-5. PubMed ID: 17547360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischemic complications of transcatheter arterial chemoembolization in liver malignancies.
    Tarazov PG; Polysalov VN; Prozorovskij KV; Grishchenkova IV; Rozengauz EV
    Acta Radiol; 2000 Mar; 41(2):156-60. PubMed ID: 10741789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma.
    Li M; Lu C; Cheng J; Zhang J; Cao C; Xu J; Xu J; Pan H; Zhong B; Tucker S; Wang D
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1437-44. PubMed ID: 19486255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TACE versus TAE as therapy for hepatocellular carcinoma.
    Pleguezuelo M; Marelli L; Misseri M; Germani G; Calvaruso V; Xiruochakis E; Manousou P; Burroughs AK
    Expert Rev Anticancer Ther; 2008 Oct; 8(10):1623-41. PubMed ID: 18925854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinico-roentogenologic findings in hepatocellular carcinoma fed by the right inferior phrenic artery at the initial chemoembolization.
    Kimura S; Okazaki M; Higashihara H; Haruno M; Nozaki Y; Urakawa H; Kora S; Shinagawa Y; Nonokuma M
    Hepatogastroenterology; 2009; 56(89):191-8. PubMed ID: 19453056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Virtual Injection Software to Aid in Microcatheter Positioning during Transarterial Chemoembolization.
    Soliman MM; Stein SI; Doustaly R; Madoff DC
    J Vasc Interv Radiol; 2019 Oct; 30(10):1646-1648. PubMed ID: 31471197
    [No Abstract]   [Full Text] [Related]  

  • 16. [An unusual complication of hepatocellular carcinoma: the pleuro-biliary fistula].
    Tirotta D; Durante V
    Recenti Prog Med; 2009 Feb; 100(2):84-6. PubMed ID: 19350800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using intravoxel incoherent motion (IVIM) MR imaging to predict lipiodol uptake in patients with hepatocellular carcinoma following transcatheter arterial chemoembolization: a preliminary result.
    Park YS; Lee CH; Kim JH; Kim IS; Kiefer B; Seo TS; Kim KA; Park CM
    Magn Reson Imaging; 2014 Jul; 32(6):638-46. PubMed ID: 24703575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter arterial chemoembolization with fine-powder cisplatin-lipiodol for HCC.
    Koizumi Y; Hirooka M; Uehara T; Kisaka Y; Uesugi K; Kumagi T; Abe M; Matsuura B; Hiasa Y; Onji M
    Hepatogastroenterology; 2011; 58(106):512-5. PubMed ID: 21661422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoembolization of hepatocellular carcinoma--what to tell the skeptics: review and meta-analysis.
    Ramsey DE; Geschwind JF
    Tech Vasc Interv Radiol; 2002 Sep; 5(3):122-6. PubMed ID: 12524642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transarterial chemotherapy alone versus transarterial chemoembolization for hepatocellular carcinoma: a randomized phase III trial.
    Okusaka T; Kasugai H; Shioyama Y; Tanaka K; Kudo M; Saisho H; Osaki Y; Sata M; Fujiyama S; Kumada T; Sato K; Yamamoto S; Hinotsu S; Sato T
    J Hepatol; 2009 Dec; 51(6):1030-6. PubMed ID: 19864035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.